Online Investor Kit

Assemble your own Investor Kit by selecting and printing from the following documents.

Corporate Presentation

Date Documents

Recent SEC Filings

Filing date Form Description Filing Group Downloads
DEFA14A

Additional proxy soliciting materials - definitive
Proxy Filings
0001104659-24-050004.rtf
0001104659-24-050004.pdf
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")
Proxy Filings
0001104659-24-049997.rtf
0001104659-24-049997.xls
0001104659-24-049997.pdf
ARS

An annual report to security holders
Annual Filings
0001104659-24-050010.rtf
0001104659-24-050010.pdf
4

Statement of changes in beneficial ownership of securities
3,4,5
0001396814-24-000037.rtf
0001396814-24-000037.xls
0001396814-24-000037.pdf
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
Other
0002007317-24-000320.rtf
0002007317-24-000320.xls
0002007317-24-000320.pdf
8-K

Report of unscheduled material events or corporate event
Current Reports
0001396814-24-000026.rtf
0001396814-24-000026.xls
0001396814-24-000026.pdf
10-K

Annual report which provides a comprehensive overview of the company for the past year
Annual Filings
0001396814-24-000030.rtf
0001396814-24-000030.xls
0001396814-24-000030.pdf
S-8

Securities offered to employees pursuant to employee benefit plans
Registration Statements
0001396814-24-000035.rtf
0001396814-24-000035.xls
0001396814-24-000035.pdf
SC 13G/A

An amendment to the SC 13G filing
Other
0001104659-24-021660.rtf
0001104659-24-021660.pdf
4

Statement of changes in beneficial ownership of securities
3,4,5
0001396814-24-000017.rtf
0001396814-24-000017.xls
0001396814-24-000017.pdf

Fact Sheets

There are currently no items available.

Recent Press Releases

Date Title and Summary
Toggle Summary Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL®
DocFind update helps Aetna members connect with surgeons trained in managing postsurgical pain using non-opioid medications PARSIPPANY, N.J. , June 15, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. today announced further collaboration with Aetna, one of the nation’s leading diversified
Toggle Summary Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers 
Aetna will reimburse for the use of EXPAREL in ambulatory surgical centers in Florida and New Jersey as part of a pilot program       PARSIPPANY, N.J. , Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aetna has announced that they will reimburse select ambulatory surgical centers (ASCs) for the use of EXPAREL ®
Toggle Summary American College of Surgeons Launches Education Program on Opioids and Surgery: Use, Abuse, and Alternatives
Pacira grant will allow for the development and distribution of resources to educate patients and surgeons on opioid use in surgical care CHICAGO , Nov. 22, 2016 (GLOBE NEWSWIRE) -- The American College of Surgeons (ACS) today announced a new multifaceted initiative to improve the knowledge and
Toggle Summary American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable Foundation, to advance the medical specialty of
Toggle Summary American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
SCHAUMBERG, Ill. and TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) today announced Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry Supporter Program to support the Society’s more than 56,000 physician anesthesiologist members to
Toggle Summary Analysis of Postsurgical Pain Management Finds Opioid-Related Adverse Events Drive Longer Hospital Stays, Greater Cost and Higher Likelihood of Readmission
Retrospective Study Published in Journal of Pain and Palliative Care Pharmacotherapy Utilized National Hospital Database and Assessed Nearly 320,000 Surgeries PARSIPPANY, N.J. --(BUSINESS WIRE)--Mar. 27, 2013-- Pacira Pharmaceuticals, Inc . (NASDAQ: PCRX) today announced data from a large-scale
Toggle Summary Animal Health Partner, Aratana Therapeutics, Announces Positive Pivotal Results for Controlling Postsurgical Pain in Dogs
PARSIPPANY, N.J. --(BUSINESS WIRE)--Jul. 15, 2015-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) announced today that Aratana Therapeutics, Inc. (NASDAQ: PETX) shared positive results from its pivotal field effectiveness study of AT-003, the company’s bupivacaine liposome injectable suspension
Toggle Summary Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use
BOCA RATON, Fla. , Nov. 29, 2017 /PRNewswire/ -- Cancer Treatment Centers of America ® (CTCA), a national network of five hospitals, and Pacira Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on opioid alternatives, today announced a new collaboration dedicated to reducing the
Toggle Summary Centers for Medicare and Medicaid Services and American Dental Association Establish New Reimbursement for EXPAREL
-- Product-specific C-code for ambulatory surgical center procedures and D-code for dental procedures to take effect January 1 , 2019 -- -- Important reimbursement milestone that will expand patient access to non-opioid strategies for postsurgical pain -- PARSIPPANY, N.J. , Nov.
Toggle Summary Correction: Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November
PARSIPPANY, N.J. , Nov. 10, 2016 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that senior leadership is scheduled to present an overview of the company at the following investor conferences in November: Jefferies 2016 London Healthcare Conference at 2:00 p.m.